Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06478277 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

UK CARDIOvascular Immune-Mediated Inflammatory Diseases (CARDIO-IMID) Registry Study

Study acronym: CARDIO-IMID
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 2024 to Feb 4, 2026
    • Study sites: 0 to 2
    • Primary and study completion dates: Jul 2028 to Aug 2028
    v3
  2. Start date: Jul 2024 to Dec 2024v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational study is to develop a large, deeply characterised cohort that will be a platform for collaborative clinical and translational research into cardiovascular (CV) disease (CVD) and Immune-mediated-inflammatory-diseases (IMID). The main aim is to evaluate whether existing blood cardiac biomarkers predict adverse cardiovascular outcomes. The study will capture standard of care CV and associated health data (clinical, biochemistry/pathology and investigations) in patients across the IMIDs. Optional biological and/or imaging sub-studies will provide additional data and/or samples for associated analyses.
Trial Details
NCT Number NCT06478277
Lead Sponsor University of Manchester
Collaborators: University of Cambridge, University of Oxford, University of Edinburgh, University of Leeds, Imperial College London, Medical Research Council, British Heart Foundation, Swansea University, British Heart Foundation Data Science Centre
Conditions
(from sponsor)		 Cardiovascular Diseases, Immune-Mediated Inflammatory Diseases
Related terms Cardiovascular Diseases
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov